Anebulo Pharmaceuticals Inc

NASDAQ ANEB

Data sourced from iex and EODHD
Download Data

Anebulo Pharmaceuticals Inc Income Statement 2020 - 2024

This table shows the Income Statement for Anebulo Pharmaceuticals Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - - - - - - - - - - - - - - -
Gross Profit
M - - - - - - - - - - - - - - -
Operating Expenses
M - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 1 2 1 1 2 2 1 1 1 1 1 1 0 0 0
Research and Development (R&D) Expenses
M 1 1 1 1 1 2 1 1 1 0 1 2 0 0 0
Other Operating Expenses
M - - - - - - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - -
Operating Income
M -2 -3 -3 -2 -3 -4 -3 -2 -2 -1 -2 -2 -1 0 0
Interest Expense
M 0 0 - 0 0 0 0 0 0 0 - 0 0 - -
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 -27 -1 0 0
EBT
M -2 -3 -2 -2 -3 -4 -3 -2 -2 -1 -2 -29 -1 0 0
Income Tax Provision
M -2 0 0 0 0 0 0 0 0 0 - 0 - - -
Income after Tax
M 0 -3 -2 -3 -3 -4 -3 -2 -2 -1 - -29 - - -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 8 0 0
Net Income
M - - - -2 -2 -4 -3 -2 -2 -1 -2 -29 -9 0 0
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 25,933,217.00 25,789,739.00 25,633,217.00 25,633,217.00 25,633,217.00 25,633,217.00 23,416,495.00 23,344,567.00 23,344,567.00 23,344,567.00 23,344,567.00 18,293,103.00 23,266,343.00 23,266,343.00 23,266,343.00
EBITDA
M -2 -3 -3 -2 -3 -4 -3 -2 -2 -1 -2 -2 -1 0 0
Depreciation and Amortization
M 2 0 0 0 0 0 0 0 0 0 0 0 - - -
EBIT
M -3 -3 -3 -2 -3 -4 -3 -2 -2 -1 -2 -2 -1 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 100.65 0.10 2.33 -2.10 2.36 -0.36 0.01 0.20 0.17 -0.17 - 0.00 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email